Live from the NIH registry
Studies recruiting near Macon right now
Top 25 of 75 recruiting studies, sorted by proximity — each links to its official registry page
A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
Colitis, Ulcerative
Phase 3
Interventional 882 participants sought
Gastroenterolgy Associates of Central GA — Macon, Georgia (4.5 mi)
· Sponsor: Janssen Research & Development, LLC
A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes
Type 1 Diabetes Mellitus With Hypoglycemia
Phase 2
Interventional 186 participants sought
East Coast Institute for Research — Macon, Georgia (4.5 mi)
· Sponsor: Zucara Therapeutics Inc.
A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 2
Narcolepsy Type 2
Phase 3
Interventional 176 participants sought
Alkermes Investigational Site — Macon, Georgia (4.5 mi)
· Sponsor: Alkermes, Inc.
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Atherosclerotic Cardiovascular Disease, Overweight
Phase 3
Interventional 12,800 participants sought
The Jones Center Clinical Research — Macon, Georgia (4.5 mi)
· Sponsor: Amgen
Cadisegliatin as Adjunctive Therapy to Insulin in Participants With Type 1 Diabetes
Diabetes Mellitus, Type 1
Phase 3
Interventional 150 participants sought
The Jones Center Clinical Research, LLC — Macon, Georgia (4.5 mi)
· Sponsor: vTv Therapeutics
This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment
Atopic Dermatitis
N/A
Observational 1,000 participants sought
Skin Care Physicians of Georgia - Macon- Site Number : 8400034 — Macon, Georgia (4.5 mi)
· Sponsor: Sanofi
A Study to Evaluate the Efficacy and Safety of Belantamab Mafodotin in Combination With Standard of Care in Participants With Relapsed-Refractory Multiple Myeloma (RRMM)
Multiple Myeloma
Phase 2
Interventional 200 participants sought
GSK Investigational Site — Macon, Georgia (4.5 mi)
· Sponsor: GlaxoSmithKline
A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Idiopathic Hypersomnia (IH)
Idiopathic Hypersomnia
Phase 3
Interventional 248 participants sought
Sleep Practitioners, LLC — Macon, Georgia (4.5 mi)
· Sponsor: Harmony Biosciences Management, Inc.
A Phase 3 Study of Rezpegaldesleukin (NKTR-358) for Patients ≥ 12 Years of Age With Moderate-to-Severe Atopic Dermatitis
Moderate-to-Severe Atopic Dermatitis
Phase 3
Interventional 510 participants sought
Nektar Investigative Site — Macon, Georgia (4.5 mi)
· Sponsor: Nektar Therapeutics
Study of Petosemtamab Plus Chemotherapy Versus Cetuximab Plus Chemotherapy in RAS and BRAF Wild-type, Unresectable or Metastatic, Left-sided Colorectal Cancer (LiGeR-CRC1)
Left-sided Colorectal Cancer
Phase 3
Interventional 960 participants sought
Central Georgia Cancer Care - Warner Robins Office — Warner Robins, Georgia (13.8 mi)
· Sponsor: Genmab
A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Narcolepsy
EDS, Cataplexy
Phase 3
Interventional 258 participants sought
Sleep Practitioners, LLC — Macon, Georgia (4.5 mi)
· Sponsor: Harmony Biosciences Management, Inc.
Project: Every Child for Younger Patients With Cancer
Adrenal Gland Pheochromocytoma, Carcinoma In Situ
N/A
Observational 75,000 participants sought
Atrium Health Navicent — Macon, Georgia (4.5 mi)
· Sponsor: Children's Oncology Group
A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
Crohn Disease
Phase 2, Phase 3
Interventional 1,092 participants sought
Gastroenterolgy Associates of Central GA — Macon, Georgia (4.5 mi)
· Sponsor: Janssen Research & Development, LLC
Single Versus Dual Implant Fixation of Distal Femur Fractures
Articular Fractures
N/A
Interventional 144 participants sought
Atrium Health Navicent — Macon, Georgia (4.5 mi)
· Sponsor: Wake Forest University Health Sciences
LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis
Metabolic Dysfunction Associated Steatohepatitis
Phase 3
Interventional 1,590 participants sought
Gastroenterology Associates of Central Georgia — Macon, Georgia (4.5 mi)
· Sponsor: Boehringer Ingelheim
Empowering Patients' Lung Cancer Screening Uptake (Empower LCS/Call+)
Lung Cancer Screening, Lung Neoplasms
N/A
Interventional 80 participants sought
Pavilion Family Medicine Center — Warner Robins, Georgia (13.8 mi)
· Sponsor: University of California, Irvine
A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (Also Known as RO7790121) in Participants With Moderately to Severely Active Ulcerative Colitis
Moderately to Severely Active Ulcerative Colitis
Phase 3
Interventional 350 participants sought
Gastroenterology Associates of Central Georgia — Macon, Georgia (4.5 mi)
· Sponsor: Hoffmann-La Roche
A Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide Versus Durvalumab, Carboplatin, and Etoposide in First-line Extensive Stage Small-Cell Lung Cancer (ES-SCLC)
Small-cell Lung Cancer, Extensive Stage Small-cell Lung Cancer
Phase 3
Interventional 330 participants sought
Central Georgia Cancer Care PC — Macon, Georgia (4.5 mi)
· Sponsor: Amgen
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Breast Neoplasms, Neoplasm Metastasis
Phase 3
Interventional 800 participants sought
Central Georgia Cancer Care — Macon, Georgia (4.5 mi)
· Sponsor: Eli Lilly and Company
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients
Non-Small Cell Lung Cancer
Phase 3
Interventional 1,600 participants sought
Central Georgia Cancer Care — Macon, Georgia (4.5 mi)
· Sponsor: Summit Therapeutics
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Diabetes Mellitus, Type 2, Hypertension
Phase 3
Interventional 11,800 participants sought
The Jones Center Clinical Research, LLC — Macon, Georgia (4.5 mi)
· Sponsor: Boehringer Ingelheim
BGB-43395 Plus Letrozole Versus CDK4/6i Plus Letrozole for Patients With Advanced or Metastatic HR+/HER2- Breast Cancer Who Have Not Received Prior Treatment for Advanced or Metastatic Disease
HR+/HER2- Breast Cancer
Phase 3
Interventional 1,056 participants sought
Central Georgia Cancer Care Macon Office — Macon, Georgia (4.5 mi)
· Sponsor: BeOne Medicines
Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
Gastric Cancer, Gastroesophageal Junction Adenocarcinoma
Phase 3
Interventional 2,130 participants sought
Research Site — Macon, Georgia (4.5 mi)
· Sponsor: AstraZeneca
A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease
Graves' Disease
Phase 2
Interventional 240 participants sought
Site Number - 1053 — Macon, Georgia (4.5 mi)
· Sponsor: Immunovant Sciences GmbH
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Breast Carcinoma, Colorectal Carcinoma
N/A
Observational 2,000 participants sought
Atrium Health Navicent — Macon, Georgia (4.5 mi)
· Sponsor: Wake Forest University Health Sciences